KBC Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75K | Sell |
660
-244
| -27% | -$27.7K | ﹤0.01% | 1392 |
|
|
2025
Q1 | $95K | Hold |
904
| – | – | ﹤0.01% | 1506 |
|
|
2024
Q4 | $97K | Buy |
904
+300
| +50% | +$32.2K | ﹤0.01% | 1579 |
|
|
2024
Q3 | $60K | Hold |
604
| – | – | ﹤0.01% | 1631 |
|
|
2024
Q2 | $51K | Hold |
604
| – | – | ﹤0.01% | 1598 |
|
|
2024
Q1 | $44K | Hold |
604
| – | – | ﹤0.01% | 1620 |
|
|
2023
Q4 | $43K | Hold |
604
| – | – | ﹤0.01% | 1631 |
|
|
2023
Q3 | $36K | Sell |
604
-625
| -51% | -$37.3K | ﹤0.01% | 1688 |
|
|
2023
Q2 | $89K | Hold |
1,229
| – | – | ﹤0.01% | 1224 |
|
|
2023
Q1 | $90K | Sell |
1,229
-202
| -14% | -$14.8K | ﹤0.01% | 1238 |
|
|
2022
Q4 | $96K | Sell |
1,431
-863
| -38% | -$57.9K | ﹤0.01% | 1217 |
|
|
2022
Q3 | $123K | Hold |
2,294
| – | – | ﹤0.01% | 1107 |
|
|
2022
Q2 | $128K | Buy |
+2,294
| New | +$128K | ﹤0.01% | 1129 |
|
|
2021
Q1 | – | Sell |
-9,278
| Closed | -$3.17M | – | 1305 |
|
|
2020
Q4 | $3.17M | Hold |
9,278
| – | – | ﹤0.01% | 946 |
|
|
2020
Q3 | $552K | Buy |
9,278
+4,681
| +102% | +$278K | ﹤0.01% | 913 |
|
|
2020
Q2 | $320K | Sell |
4,597
-30,323
| -87% | -$2.11M | ﹤0.01% | 1103 |
|
|
2020
Q1 | $1.58M | Sell |
34,920
-29,489
| -46% | -$1.34M | 0.01% | 597 |
|
|
2019
Q4 | $4.19M | Buy |
+64,409
| New | +$4.19M | 0.03% | 511 |
|
|
2016
Q1 | – | Sell |
-33,583
| Closed | -$2.27M | – | 1277 |
|
|
2015
Q4 | $2.27M | Sell |
33,583
-3,797
| -10% | -$257K | 0.04% | 445 |
|
|
2015
Q3 | $2M | Buy |
37,380
+35,089
| +1,532% | +$1.87M | 0.04% | 435 |
|
|
2015
Q2 | $144K | Buy |
+2,291
| New | +$144K | ﹤0.01% | 1183 |
|
|
2014
Q4 | – | Sell |
-8,204
| Closed | -$240K | – | 1456 |
|
|
2014
Q3 | $240K | Hold |
8,204
| – | – | 0.01% | 938 |
|
|
2014
Q2 | $319K | Buy |
8,204
+6,853
| +507% | +$266K | ﹤0.01% | 1004 |
|
|
2014
Q1 | $57K | Hold |
1,351
| – | – | ﹤0.01% | 1197 |
|
|
2013
Q4 | $44K | Buy |
+1,351
| New | +$44K | ﹤0.01% | 1236 |
|